Cardiac biomarkers in acute myocardial infarction

International Journal of Cardiology

Volumn 164, Issue 3, 2013, Pages 282-294

  Aldous, Sally J ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

cardiac biomarkers; High sensitivity troponin; Myocardial infarction; Novel biomarkers; Prognostic utility; Troponin

Indexed keywords

ADIPONECTIN; ADRENOMEDULLIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APELIN; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CD40 LIGAND; CELL ADHESION MOLECULE; CHOLINE; COPEPTIN; CREATINE KINASE; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 6; ISCHEMIA MODIFIED ALBUMIN; ISOPROSTANE DERIVATIVE; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYELOPEROXIDASE; MYOGLOBIN; N(G),N(G) DIMETHYLARGININE; PLACENTAL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROCALCITONIN; TROPONIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CREATINE KINASE MB; GLYCOPROTEIN VI; MATRIX METALLOPROTEINASE; MICRORNA;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART REINFARCTION; HUMAN; LIMIT OF DETECTION; MORTALITY; POINT OF CARE TESTING; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SENSITIVITY AND SPECIFICITY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC ACCURACY; FALSE POSITIVE RESULT; INFLAMMATION;

BIOLOGICAL MARKERS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; PROGNOSIS; RISK FACTORS;

EID: 84884211409     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.081     Document Type: Review

References (273)

1. A. Dolci, and M. Panteghini The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more Clin Chim Acta 369 2006 179 187
2. J.H. Ladenson A personal history of markers of myocyte injury [myocardial infarction] Clin Chim Acta 381 2007 3 8
3. R.S. Ruzich Cardiac enzymes. How to use serial determinations to confirm acute myocardial infarction Postgrad Med 92 1992 85 89 [92]
4. T.H. Lee, and L. Goldman Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis Ann Intern Med 105 1986 221 233
5. World Health Organization Expert Commitee Hypertension and coronary heart disease: classification and criteria for epidemiological studies Technical report series number 168 1959 World Health Organization Geneva
6. C.C. Johnston, and E.C. Bolton Cardiac enzymes Ann Emerg Med 11 1982 27 35
7. Troponin T and myocardial damage Lancet 338 1991 23 24
8. F.S. Apple Acute myocardial infarction and coronary reperfusion. Serum cardiac markers for the 1990s Am J Clin Pathol 97 1992 217 226
9. J.F. Nowakowski Use of cardiac enzymes in the evaluation of acute chest pain Ann Emerg Med 15 1986 354 360
10. T.R. Navin, and W.D. Hager Creatine kinase MB isoenzyme in the evaluation of myocardial infarction Curr Probl Cardiol 3 1979 1 32
11. S.B. Rosalki, R. Roberts, H.A. Katus, E. Giannitsis, J.H. Ladenson, and F.S. Apple Cardiac biomarkers for detection of myocardial infarction: perspectives from past to present Clin Chem 50 2004 2205 2213
12. A.H. Wu, R. Valdes Jr., and F.S. Apple Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction Clin Chem 40 1994 900 907
13. J.A. Lott, and J.M. Stang Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis Clin Chem 26 1980 1241 1250
14. T. Yamada, A. Matsumori, S. Tamaki, and S. Sasayama Myosin light chain I grade: a simple marker for the severity and prognosis of patients with acute myocardial infarction Am Heart J 135 1998 329 334
15. L.G. Futterman, and L. Lemberg Novel markers in the acute coronary syndrome: BNP, IL-6, PAPP-A Am J Crit Care 11 2002 168 172
16. B. Cummins, M.L. Auckland, and P. Cummins Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction Am Heart J 113 1987 1333 1344
17. J. Mair, N. Genser, and D. Morandell Cardiac troponin I in the diagnosis of myocardial injury and infarction Clin Chim Acta 245 1996 19 38
18. M.C. Kontos, and R.L. Jesse Evaluation of the emergency department chest pain patient Am J Cardiol 85 2000 32B 39B
19. S. Mann, J. Tietjens, K. Law, and R. Elley Troponin testing for chest pain in primary healthcare: a New Zealand audit N Z Med J 119 2006 U2083
20. W. Gerhardt, H. Katus, and J. Ravkilde S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB Clin Chem 37 1991 1405 1411
21. J. Mair, E. Artner-Dworzak, and P. Lechleitner Cardiac troponin T in diagnosis of acute myocardial infarction Clin Chem 37 1991 845 852
22. H.A. Katus, A. Remppis, and F.J. Neumann Diagnostic efficiency of troponin T measurements in acute myocardial infarction Circulation 83 1991 902 912
23. A.J. Bakker, M.J. Koelemay, and J.P. Gorgels Failure of new biochemical markers to exclude acute myocardial infarction at admission Lancet 342 1993 1220 1222
24. C. Larue, C. Calzolari, J.P. Bertinchant, F. Leclercq, R. Grolleau, and B. Pau Cardiac-specific immunoenzymometric assay of troponin I in the early phase of acute myocardial infarction Clin Chem 39 1993 972 979
25. R.J. de Winter, R.W. Koster, A. Sturk, and G.T. Sanders Value of myoglobin, troponin T, and CK-MBmass in ruling out an acute myocardial infarction in the emergency room Circulation 92 1995 3401 3407
26. J. Mair, J. Smidt, P. Lechleitner, F. Dienstl, and B. Puschendorf A decision tree for the early diagnosis of acute myocardial infarction in nontraumatic chest pain patients at hospital admission Chest 108 1995 1502 1509
27. C.W. Hamm, and H.A. Katus New biochemical markers for myocardial cell injury Curr Opin Cardiol 10 1995 355 360
28. A.J. Bakker, J.P. Gorgels, B. van Vlies, F.D. Haagen, and R. Smits The mass concentrations of serum troponin T and creatine kinase-MB are elevated before creatine kinase and creatine kinase-MB activities in acute myocardial infarction Eur J Clin Chem Clin Biochem 31 1993 715 724
29. J. Ravkilde, M. Horder, and W. Gerhardt Diagnostic performance and prognostic value of serum troponin T in suspected acute myocardial infarction Scand J Clin Lab Invest 53 1993 677 685
30. W. Gerhardt, L. Ljungdahl, and A.K. Herbert Troponin-T and CK MB (mass) in early diagnosis of ischemic myocardial injury. The Helsingborg Study, 1992 Clin Biochem 26 1993 231 240
31. J. Mair, I. Wagner, and B. Puschendorf Cardiac troponin I to diagnose myocardial injury Lancet 341 1993 838 839
32. V. Bhayana, S. Cohoe, T.G. Pellar, G. Jablonsky, and A.R. Henderson Combination (multiple) testing for myocardial infarction using myoglobin, creatine kinase-2 (mass), and troponin T Clin Biochem 27 1994 395 406
33. A. Burlina, M. Zaninotto, S. Secchiero, D. Rubin, and F. Accorsi Troponin T as a marker of ischemic myocardial injury Clin Biochem 27 1994 113 121
34. F.S. Apple, E. Voss, L. Lund, L. Preese, C.R. Berger, and T.D. Henry Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapy Clin Chim Acta 237 1995 59 66
35. B. Lindahl, P. Venge, and L. Wallentin Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. The FRISC study group Circulation 93 1996 1651 1657
36. G.D. Kerr, and D.R. Dunt Early prediction of risk in patients with suspected unstable angina using serum troponin T Aust N Z J Med 27 1997 554 560
37. V.V. Murthy, and A. Karmen Troponin-T as a serum marker for myocardial infarction J Clin Lab Anal 11 1997 125 128
38. M. Galvani, D. Ferrini, R. Puggioni, S. Ruggeri, and F. Ottani New markers for early diagnosis of acute myocardial infarction Int J Cardiol 65 Suppl. 1 1998 S17 S22
39. A.J. Bakker, M.J. Koelemay, and J.P. Gorgels Troponin T and myoglobin at admission: value of early diagnosis of acute myocardial infarction Eur Heart J 15 1994 45 53
40. P.O. Collinson, and P.J. Stubbs The prognostic value of serum troponin T in unstable angina N Engl J Med 327 1992 1760 1761
41. F.S. Apple, A.H. Wu, and R. Valdes Jr. Serum cardiac troponin T concentrations in hospitalized patients without acute myocardial infarction Scand J Clin Lab Invest 56 1996 63 68
42. R.J. de Winter, R.W. Koster, J.H. Schotveld, A. Sturk, J.P. van Straalen, and G.T. Sanders Prognostic value of troponin T, myoglobin, and CK-MB mass in patients presenting with chest pain without acute myocardial infarction Heart 75 1996 235 239
43. A.G. Rebuzzi, G. Quaranta, and G. Liuzzo Incremental prognostic value of serum levels of troponin T and C-reactive protein on admission in patients with unstable angina pectoris Am J Cardiol 82 1998 715 719
44. A.G. Olatidoye, A.H. Wu, Y.J. Feng, and D. Waters Prognostic role of troponin T versus troponin I in unstable angina pectoris for cardiac events with meta-analysis comparing published studies Am J Cardiol 81 1998 1405 1410
45. V. Gokhan Cin, H. Gok, and B. Kaptanoglu The prognostic value of serum troponin T in unstable angina Int J Cardiol 53 1996 237 244
46. P. Stubbs, P. Collinson, D. Moseley, T. Greenwood, and M. Noble Prospective study of the role of cardiac troponin T in patients admitted with unstable angina BMJ 313 1996 262 264
47. B. Lindahl, B. Andren, J. Ohlsson, P. Venge, and L. Wallentin Noninvasive risk stratification in unstable coronary artery disease: exercise test and biochemical markers. FRISC Study Group Am J Cardiol 80 1997 40E 44E
48. T.L. Pettijohn, T. Doyle, A.M. Spiekerman, L.E. Watson, M.W. Riggs, and M.E. Lawrence Usefulness of positive troponin-T and negative creatine kinase levels in identifying high-risk patients with unstable angina pectoris Am J Cardiol 80 1997 510 511
49. A.T. Yan, R.T. Yan, and M. Tan Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients Eur Heart J 25 2004 2006 2012
50. S.G. Goodman, P.G. Steg, and K.A. Eagle The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE) Am Heart J 151 2006 654 660
51. A.H. Wu, and P.L. Lane Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases Clin Chem 41 1995 1228 1233
52. A.H. Wu, S.A. Abbas, and S. Green Prognostic value of cardiac troponin T in unstable angina pectoris Am J Cardiol 76 1995 970 972
53. P. Stubbs, P. Collinson, D. Moseley, T. Greenwood, and M. Noble Prognostic significance of admission troponin T concentrations in patients with myocardial infarction Circulation 94 1996 1291 1297
54. Y. Seino, Y. Tomita, T. Takano, and H. Hayakawa Early identification of cardiac events with serum troponin T in patients with unstable angina Lancet 342 1993 1236 1237
55. H.A. Katus, N. Frey, and M. Muller-Bardorff Cardiac troponins in patients with chest pain N Engl J Med 338 1998 1314 1315
56. T.H. Lee, and L. Goldman Evaluation of the patient with acute chest pain N Engl J Med 342 2000 1187 1195
57. G.S. Reeder Contemporary diagnosis and management of unstable angina Mayo Clin Proc 75 2000 953 957
58. M.J. Quinn, and D.J. Moliterno Troponins in acute coronary syndromes: more TACTICS for an early invasive strategy JAMA 286 2001 2461 2462
59. C.W. Hamm, M. Bertrand, and E. Braunwald Acute coronary syndrome without ST elevation: implementation of new guidelines Lancet 358 2001 1533 1538
60. R. Doukky, and J.E. Calvin Part II: risk stratification in patients with unstable angina and non-ST segment elevation myocardial infarction: evidence-based review J Invasive Cardiol 14 2002 254 262
61. M. Plebani Biochemical markers of cardiac damage: from efficiency to effectiveness Clin Chim Acta 311 2001 3 7
62. C.P. Cannon Evidence-based risk stratification to target therapies in acute coronary syndromes Circulation 106 2002 1588 1591
63. G.L. Alonsozana, and R.H. Christenson The case for cardiac troponin T: marker for effective risk stratification of patients with acute cardiac ischemia Clin Chem 42 1996 803 808
64. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction Eur Heart J 21 2000 1502 1513
65. L.K. Newby, J.S. Alpert, E.M. Ohman, K. Thygesen, and R.M. Califf Changing the diagnosis of acute myocardial infarction: implications for practice and clinical investigations Am Heart J 144 2002 957 980
66. R. Fox Impact of revised criteria for myocardial infarction Circulation 106 2002 e9033
67. J.L. Ferguson, G.J. Beckett, M. Stoddart, S.W. Walker, and K.A. Fox Myocardial infarction redefined: the new ACC/ESC definition, based on cardiac troponin, increases the apparent incidence of infarction Heart 88 2002 343 347
68. G. Amit, H. Gilutz, C. Cafri, A. Wolak, R. Ilia, and D. Zahger What have the new definition of acute myocardial infarction and the introduction of troponin measurement done to the coronary care unit? Impacts on admission rate, length of stay, case mix and mortality Cardiology 102 2004 171 176
69. V. Salomaa, H. Koukkunen, and M. Ketonen A new definition for myocardial infarction: what difference does it make? Eur Heart J 26 2005 1719 1725
70. V.L. Roger, J.M. Killian, and S.A. Weston Redefinition of myocardial infarction: prospective evaluation in the community Circulation 114 2006 790 797
71. S.Z. Abildstrom, S. Rasmussen, and M. Madsen Changes in hospitalization rate and mortality after acute myocardial infarction in Denmark after diagnostic criteria and methods changed Eur Heart J 26 2005 990 995
72. K. Thygesen, J.S. Alpert, and H.D. White Universal definition of myocardial infarction Circulation 116 2007 2634 2653
73. A.H. Wu, and Y.J. Feng Biochemical differences between cTnT and cTnI and their significance for diagnosis of acute coronary syndromes Eur Heart J 19 Suppl. N 1998 N25 N29
74. O. Hetland, and K. Dickstein Cardiac troponins I and T in patients with suspected acute coronary syndrome: a comparative study in a routine setting Clin Chem 44 1998 1430 1436
75. A.H. Wu, Y.J. Feng, and R. Moore Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization Clin Chem 44 1998 1198 1208
76. J.R. Tate Troponin revisited 2008: assay performance Clin Chem Lab Med 46 2008 1489 1500
77. M. Panteghini, D.M. Bunk, and R.H. Christenson Standardization of troponin I measurements: an update Clin Chem Lab Med 46 2008 1501 1506
78. M. Panteghini Assay-related issues in the measurement of cardiac troponins Clin Chim Acta 402 2009 88 93
79. P.O. Collinson Troponin T or troponin I or CK-MB (or none?) Eur Heart J 19 Suppl. N 1998 N16 N24
80. J.P. Chapelle Cardiac troponin I and troponin T: recent players in the field of myocardial markers Clin Chem Lab Med 37 1999 11 20
81. R.H. Christenson, D.R. Cervelli, R.S. Bauer, and M. Gordon Stratus CS cardiac troponin I method: performance characteristics including imprecision at low concentrations Clin Biochem 37 2004 679 683
82. S.H. Tsai, S.J. Chu, C.W. Hsu, S.M. Cheng, and S.P. Yang Use and interpretation of cardiac troponins in the ED Am J Emerg Med 26 2008 331 341
83. F.S. Apple, S.W. Smith, L.A. Pearce, R. Ler, and M.M. Murakami Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome Clin Chem 54 2008 723 728
84. G. Casals, X. Filella, and J.L. Bedini Evaluation of a new ultrasensitive assay for cardiac troponin I Clin Biochem 40 2007 1406 1413
85. F.S. Apple, L.A. Pearce, S.W. Smith, J.M. Kaczmarek, and M.M. Murakami Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events Clin Chem 55 2009 930 937
86. J. Mair, D. Morandell, N. Genser, P. Lechleitner, F. Dienstl, and B. Puschendorf Equivalent early sensitivities of myoglobin, creatine kinase MB mass, creatine kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction Clin Chem 41 1995 1266 1272
87. L. Babuin, and A.S. Jaffe Troponin: the biomarker of choice for the detection of cardiac injury CMAJ 173 2005 1191 1202
88. S. Jossi, S.L. Gordon, M.A. Legge, and G.P. Armstrong All troponins are not created equal Intern Med J 36 2006 325 327
89. M. Mockel, O. Danne, and A. Schmidt Reference values for cardiac troponins I and T in a goal-oriented concept of health: cardiac marker values in a series of outpatients without acute coronary syndromes Clin Chim Acta 342 2004 83 86
90. J.H. Stromme, O. Johansen, M. Brekke, I. Seljeflot, and H. Arnesen Markers of myocardial injury in blood following PTCA: a comparison of CKMB, cardiospecific troponin T and troponin I Scand J Clin Lab Invest 58 1998 693 699
91. R.H. Christenson, S.H. Duh, and L.K. Newby Cardiac troponin T and cardiac troponin I: relative values in short-term risk stratification of patients with acute coronary syndromes. GUSTO-IIa Investigators Clin Chem 44 1998 494 501
92. K. Penttila, I. Penttila, and R. Bonnell Comparison of the troponin T and troponin I ELISA tests, as measured by microplate immunoassay techniques, in diagnosing acute myocardial infarction Eur J Clin Chem Clin Biochem 35 1997 767 774
93. A. Eisenman, V. Rusetski, D. Avital, J. Stolero, and T. Snitkovsky Are all troponin assays equivalent in the emergency department? Singapore Med J 46 2005 325 327
94. D.A. Morrow, and E.M. Antman Evaluation of high-sensitivity assays for cardiac troponin Clin Chem 55 2009 5 8
95. P. Venge, S. James, L. Jansson, and B. Lindahl Clinical performance of two highly sensitive cardiac troponin I assays Clin Chem 55 2009 109 116
96. S. Gupta, and P. Alagona Jr. Troponins: not always a myocardial infarction Am J Med 121 2008 e25 [author reply e9]
97. H.D. White Will new higher-precision troponins lead to clarity or confusion? Curr Opin Cardiol 23 2008 292 295
98. F.S. Apple, S.W. Smith, and L.A. Pearce Use of the bioMerieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome Clin Chim Acta 390 2008 72 75
99. M. O'Donoghue, and D.A. Morrow The future of biomarkers in the management of patients with acute coronary syndromes Curr Opin Cardiol 23 2008 309 314
100. A.H. Wu, and A.S. Jaffe The clinical need for high-sensitivity cardiac troponin assays for acute coronary syndromes and the role for serial testing Am Heart J 155 2008 208 214
101. S.J. Aldous, C.M. Florkowski, and I.G. Crozier Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department Ann Clin Biochem 48 2011 241 248
102. M.S. Sabatine, D.A. Morrow, J.A. de Lemos, P. Jarolim, and E. Braunwald Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 Eur Heart J 30 2009 162 169
103. P. Venge, B. Lagerqvist, E. Diderholm, B. Lindahl, and L. Wallentin Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II substudy) Am J Cardiol 89 2002 1035 1041
104. M. Bonaca, B. Scirica, and M. Sabatine Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I J Am Coll Cardiol 55 2010 2118 2124
105. P.A. Kavsak, X. Wang, D.T. Ko, A.R. MacRae, and A.S. Jaffe Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population Clin Chem 55 2009 1809 1815
106. S.J. Aldous, C.M. Florkowski, and I.G. Crozier High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain Ann Clin Biochem 48 2011 249 255
107. S. Agewall, T. Olsson, and C. Lowbeer Usefulness of troponin levels below the diagnostic cut-off level for acute myocardial infarction in predicting prognosis in unselected patients admitted to the coronary care unit Am J Cardiol 99 2007 1357 1359
108. S. Gupta, and J.A. de Lemos Use and misuse of cardiac troponins in clinical practice Prog Cardiovasc Dis 50 2007 151 165
109. A.H. Wu, A.S. Jaffe, and F.S. Apple National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure Clin Chem 53 2007 2086 2096
110. A.H. Wu Interpretation of high sensitivity cardiac troponin I results: reference to biological variability in patients who present to the emergency room with chest pain: case report series Clin Chim Acta 401 2009 170 174
111. W.L. Miller, K.A. Hartman, and M.F. Burritt Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time Circulation 116 2007 249 257
112. S.J. Aldous, A.M. Richards, and L. Cullen Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction Clin Chem 57 2011 1154 1160
113. T. Reichlin, A. Irfan, and R. Twerenbold Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction Circulation 124 2011 136 145
114. C.W. Hamm New serum markers for acute myocardial infarction N Engl J Med 331 1994 607 608
115. M.C. Kontos, R. Garg, and F.P. Anderson Ability of myoglobin to predict mortality in patients admitted for exclusion of myocardial infarction Am J Emerg Med 25 2007 873 879
116. A. Palazzuoli, J. Deckers, and A. Calabro Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function Am J Cardiol 98 2006 1322 1328
117. A. Colli, M. Josa, J.L. Pomar, C.A. Mestres, and T. Gherli Heart fatty acid binding protein in the diagnosis of myocardial infarction: where do we stand today? Cardiology 108 2007 4 10
118. Y. Kim, H. Kim, and S.Y. Kim Automated heart-type fatty acid-binding protein assay for the early diagnosis of acute myocardial infarction Am J Clin Pathol 134 2010 157 162
119. S. Charpentier, J.L. Ducasse, and M. Cournot Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department Acad Emerg Med 17 2010 27 35
120. G. Haltern, S. Peiniger, A. Bufe, G. Reiss, H. Gulker, and T. Scheffold Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction Am J Cardiol 105 2010 1 9
121. P. Mad, H. Domanovits, and C. Fazelnia Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction QJM 100 2007 203 210
122. O. Ruzgar, A.K. Bilge, and Z. Bugra The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band Heart Vessels 21 2006 309 314
123. S.S. Jolly, H. Shenkman, and D. Brieger Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events Heart 97 2011 197 202
124. S. Hjortshoj, S.R. Kristensen, and J. Ravkilde Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome Am J Emerg Med 28 2010 170 176
125. B.Y. Cingozbay, N. Ozmen, and N. Canbolat Diagnostic value of ischaemia-modified albumin for predicting myocardial ischaemia during myocardial perfusion scintigraphy J Int Med Res 36 2008 147 151
126. R. Sharma, D.C. Gaze, and D. Pellerin Evaluation of ischaemia-modified albumin as a marker of myocardial ischaemia in end-stage renal disease Clin Sci (Lond) 113 2007 25 32
127. L. Keating, J.R. Benger, and R. Beetham The PRIMA study: presentation ischaemia-modified albumin in the emergency department Emerg Med J 23 2006 764 768
128. J.R. Duffy, and M. Salerno New blood test to measure heart attack risk: C-reactive protein J Cardiovasc Nurs 19 2004 425 429
129. S. De Servi, M. Mariani, G. Mariani, and A. Mazzone C-reactive protein increase in unstable coronary disease cause or effect? J Am Coll Cardiol 46 2005 1496 1502
130. E.M. Antman, C.H. McCabe, and E.P. Gurfinkel Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial Circulation 100 1999 1593 1601
131. M.L. Simoons Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial Lancet 357 2001 1915 1924
132. A.J. Scheen JUPITER: reduction by rosuvastatin of cardiovascular events and mortality in healthy subjects without hyperlipidaemia but with elevated C-reactive protein Rev Med Liege 63 2008 749 753
133. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators Lancet 354 1999 701 707
134. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE Study Lancet 349 1997 1429 1435
135. J. Wang, S. Zhang, Y. Jin, G. Qin, L. Yu, and J. Zhang Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome Int J Cardiol 115 2007 361 365
136. Y. Miyao, H. Yasue, and H. Ogawa Elevated plasma interleukin-6 levels in patients with acute myocardial infarction Am Heart J 126 1993 1299 1304
137. W. Kosmala, M. Przewlocka-Kosmala, and W. Mazurek Proinflammatory cytokines and myocardial viability in patients after acute myocardial infarction Int J Cardiol 101 2005 449 456
138. N.G. Frangogiannis, C.W. Smith, and M.L. Entman The inflammatory response in myocardial infarction Cardiovasc Res 53 2002 31 47
139. H. Zeitler, Y. Ko, and C. Zimmermann Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction Eur J Med Res 2 1997 389 394
140. S.Q. Khan, D. Kelly, P. Quinn, J.E. Davies, and L.L. Ng Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction Heart 93 2007 826 831
141. E. Cavusoglu, C. Ruwende, and C. Eng Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome Am J Cardiol 99 2007 1364 1368
142. K.M. Eggers, M. Dellborg, and N. Johnston Myeloperoxidase is not useful for the early assessment of patients with chest pain Clin Biochem 43 2010 240 245
143. W. Hochholzer, D.A. Morrow, and R.P. Giugliano Novel biomarkers in cardiovascular disease: update 2010 Am Heart J 160 2010 583 594
144. E.M. Thorn, and I.A. Khan Pregnancy-associated plasma protein-A: an emerging cardiac biomarker Int J Cardiol 117 2007 370 372
145. T. Brugger-Andersen, O. Hetland, V. Ponitz, H. Grundt, and D.W. Nilsen The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction Thromb Res 119 2007 415 421
146. H. Aarsetoy, T. Brugger-Andersen, O. Hetland, H. Grundt, and D.W. Nilsen Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand, pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction Thromb Haemost 95 2006 329 336
147. A. Bayes-Genis, C.A. Conover, and M.T. Overgaard Pregnancy-associated plasma protein A as a marker of acute coronary syndromes N Engl J Med 345 2001 1022 1029
148. D.N. Tziakas, G.K. Chalikias, and E.I. Hatzinikolaou N-terminal pro-B-type natriuretic peptide and matrix metalloproteinases in early and late left ventricular remodeling after acute myocardial infarction Am J Cardiol 96 2005 31 34
149. J. Nurkic, F. Ljuca, and M. Nurkic Biomarkers of plaque instability in acute coronary syndrome patients Med Arh 64 2010 103 106
150. Y. Ohashi, S. Kawashima, and T. Mori Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction Int J Cardiol 112 2006 52 58
151. A. Malarstig, B. Lindahl, L. Wallentin, and A. Siegbahn Soluble CD40L levels are regulated by the - 3459 A>G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non-ST elevation acute coronary syndrome Arterioscler Thromb Vasc Biol 26 2006 1667 1673
152. N.L. Cruden, C. Graham, S.A. Harding, C.A. Ludlam, K.A. Fox, and D.E. Newby Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction Thromb Res 118 2006 189 197
153. C. Heeschen, S. Dimmeler, and C.W. Hamm Soluble CD40 ligand in acute coronary syndromes N Engl J Med 348 2003 1104 1111
154. J.M. Wallace, J.C. Freeburn, and W.S. Gilmore The assessment of platelet derived growth factor concentration in post myocardial infarction and stable angina patients Ann Clin Biochem 35 1998 236 241
155. A. Tahara, M. Yasuda, and H. Itagane Plasma levels of platelet-derived growth factor in normal subjects and patients with ischemic heart disease Am Heart J 122 1991 986 992
156. Y. Kodama, Y. Kitta, and T. Nakamura Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction J Am Coll Cardiol 48 2006 43 50
157. H. Iwama, S. Uemura, and N. Naya Cardiac expression of placental growth factor predicts the improvement of chronic phase left ventricular function in patients with acute myocardial infarction J Am Coll Cardiol 47 2006 1559 1567
158. B. Lindahl, E. Diderholm, B. Lagerqvist, P. Venge, and L. Wallentin Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy J Am Coll Cardiol 38 2001 979 986
159. I.B. Squire, S. Orn, and L.L. Ng Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy J Card Fail 11 2005 492 497
160. A.M. Richards, M.G. Nicholls, and E.A. Espiner B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction Circulation 107 2003 2786 2792
161. A.M. Richards, M.G. Nicholls, and T.G. Yandle Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction Circulation 97 1998 1921 1929
162. A.M. Richards, M.G. Nicholls, and T.G. Yandle Neuroendocrine prediction of left ventricular function and heart failure after acute myocardial infarction. The Christchurch Cardioendocrine Research Group Heart 81 1999 114 120
163. T. Omland, A.M. Richards, R. Wergeland, and H. Vik-Mo B-type natriuretic peptide and long-term survival in patients with stable coronary artery disease Am J Cardiol 95 2005 24 28
164. S.Q. Khan, P. Quinn, J.E. Davies, and L.L. Ng N-terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction Heart 94 2008 40 43
165. H. Steen, S. Futterer, C. Merten, C. Junger, H.A. Katus, and E. Giannitsis Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction J Cardiovasc Magn Reson 9 2007 749 758
166. G. Kwan, S.R. Isakson, J. Beede, P. Clopton, A.S. Maisel, and R.L. Fitzgerald Short-term serial sampling of natriuretic peptides in patients presenting with chest pain J Am Coll Cardiol 49 2007 1186 1192
167. S. Suzuki, M. Yoshimura, and M. Nakayama Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis Circulation 110 2004 1387 1391
168. S.D. Wiviott, J.A. de Lemos, and D.A. Morrow Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes Clin Chim Acta 346 2004 119 128
169. S. Talwar, I.B. Squire, and P.F. Downie Profile of plasma N-terminal proBNP following acute myocardial infarction; correlation with left ventricular systolic dysfunction Eur Heart J 21 2000 1514 1521
170. J.A. de Lemos, and D.A. Morrow Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes Am Heart J 153 2007 450 453
171. G. Ndrepepa, S. Braun, and J. Mehilli N-terminal pro-brain natriuretic peptide on admission in patients with acute myocardial infarction and correlation with scintigraphic infarct size, efficacy of reperfusion, and prognosis Am J Cardiol 97 2006 1151 1156
172. M. Grabowski, K.J. Filipiak, and G. Karpinski Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty Am Heart J 148 2004 655 662
173. S.K. James, B. Lindahl, and A. Siegbahn N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy Circulation 108 2003 275 281
174. D.A. Morrow, J.A. de Lemos, and M.S. Sabatine Evaluation of B-type
175. T. Omland, A. Persson, and L. Ng N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes Circulation 106 2002 2913 2918
176. A.M. Kuklinska, B. Sobkowicz, and B. Mroczko Prognostic significance of the admission plasma B-type natriuretic peptide measurement in patients with first ST-elevation myocardial infarction in comparison with C-reactive protein and TIMI risk score Clin Chim Acta 382 2007 106 111
177. M. Grabowski, K.J. Filipiak, and L.A. Malek Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty Int J Cardiol 115 2007 386 390
178. C. Heeschen, C.W. Hamm, V. Mitrovic, N.H. Lantelme, and H.D. White N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes Circulation 110 2004 3206 3212
179. O. Bazzino, J.J. Fuselli, F. Botto, D. Perez De Arenaza, C. Bahit, and J. Dadone Relative value of N-terminal probrain natriuretic peptide, TIMI risk score, ACC/AHA prognostic classification and other risk markers in patients with non-ST-elevation acute coronary syndromes Eur Heart J 25 2004 859 866
180. T. Jernberg, M. Stridsberg, P. Venge, and B. Lindahl N-terminal pro brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation J Am Coll Cardiol 40 2002 437 445
181. T. Omland, J.A. de Lemos, and D.A. Morrow Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes Am J Cardiol 89 2002 463 465
182. T. Omland, A. Aakvaag, and V.V. Bonarjee Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
183. B.P. Paelinck, C.J. Vrints, and J.J. Bax Relation of B-type natriuretic peptide early after acute myocardial infarction to left ventricular diastolic function and extent of myocardial damage determined by magnetic resonance imaging Am J Cardiol 97 2006 1146 1150
184. S. Blankenberg, M.J. McQueen, and M. Smieja Comparative impact of multiple biomarkers and N-Terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study Circulation 114 2006 201 208
185. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators N Engl J Med 338 1998 1488 1497
186. F. Windhausen, A. Hirsch, and G.T. Sanders N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy Am Heart J 153 2007 485 492
187. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
188. T. Yasu, T. Nishikimi, and N. Kobayashi Up-regulated synthesis of mature-type adrenomedullin in coronary circulation immediately after reperfusion in patients with anterior acute myocardial infarction Regul Pept 129 2005 161 166
189. S.A. Hamid, and G.F. Baxter Adrenomedullin: regulator of systemic and cardiac homeostasis in acute myocardial infarction Pharmacol Ther 105 2005 95 112
190. B. Michorowski, and L. Ceremuzynski The renin-angiotensin-aldosterone system and the clinical course of acute myocardial infarction Eur Heart J 4 1983 259 264
191. J.D. Blumenfeld, J.E. Sealey, and M.H. Alderman Plasma renin activity in the emergency department and its independent association with acute myocardial infarction Am J Hypertens 13 2000 855 863
192. V.J. Dzau Renin and myocardial infarction in hypertension N Engl J Med 324 1991 1128 1130
193. F. Beygui, J.P. Collet, and J.J. Benoliel High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction Circulation 114 2006 2604 2610
194. J. Herlitz, F. Waagstein, J. Lindqvist, K. Swedberg, and A. Hjalmarson Effect of metoprolol on the prognosis for patients with suspected acute myocardial infarction and indirect signs of congestive heart failure (a subgroup analysis of the Goteborg Metoprolol Trial) Am J Cardiol 80 1997 40J 44J
195. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group Lancet 1 1988 921 923
196. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group Eur Heart J 6 1985 199 226
197. G. Olsson Thromboatherosclerotic complications in hypertensives: results of the Stockholm Metoprolol (secondary prevention) Trial Am Heart J 116 1988 334 338
198. G. Pedrazzini, E. Santoro, and R. Latini Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial Am Heart J 155 2008 388 394
199. M.J. McQueen, E. Lonn, H.C. Gerstein, J. Bosch, and S. Yusuf The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences Scand J Clin Lab Invest Suppl 240 2005 143 156
200. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group Lancet 345 1995 669 685
201. M.P. Tokmakova, H. Skali, and S. Kenchaiah Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study Circulation 110 2004 3667 3673
202. C. Torp-Pedersen, and L. Kober Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation Lancet 354 1999 9 12
203. C. Borghi, P. Marino, P. Zardini, B. Magnani, S. Collatina, and E. Ambrosioni Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study. FAMIS Working Party Am Heart J 136 1998 213 225
204. J.L. Gayet The OPTIMAAL trial: losartan or captopril after acute myocardial infarction Lancet 360 2002 1884 1885 [author reply 5]
205. A.P. Maggioni, and G. Fabbri VALIANT (VALsartan In Acute myocardial iNfarcTion) trial Expert Opin Pharmacother 6 2005 507 512
206. B. Pitt, G. Bakris, L.M. Ruilope, L. DiCarlo, and R. Mukherjee Serum potassium and clinical outcomes in the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) Circulation 118 2008 1643 1650
207. R.M. LeLeiko, C.S. Vaccari, and S. Sola Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome Am J Cardiol 104 2009 638 643
208. O. Danne, M. Mockel, and C. Lueders Prognostic implications of elevated whole blood choline levels in acute coronary syndromes Am J Cardiol 91 2003 1060 1067
209. K.M. Eggers, T. Kempf, T. Allhoff, B. Lindahl, L. Wallentin, and K.C. Wollert Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain Eur Heart J 29 2008 2327 2335
210. T. Kempf, E. Bjorklund, and S. Olofsson Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction Eur Heart J 28 2007 2858 2865
211. K.C. Wollert, T. Kempf, and T. Peter Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome Circulation 115 2007 962 971
212. L. You, L. Li, F. Zhang, Q. Xu, and J. Ren A pilot study of the clinical relevance of the relationship between the serum level of pregnancy-associated plasma protein A and the degree of acute coronary syndrome J Int Med Res 38 2010 625 632
213. T. Reichlin, W. Hochholzer, and C. Stelzig Incremental value of copeptin for rapid rule out of acute myocardial infarction J Am Coll Cardiol 54 2009 60 68
214. D. Staub, N.G. Morgenthaler, and C. Buser Use of copeptin in the detection of myocardial ischemia Clin Chim Acta 399 2009 69 73
215. D. Kelly, I.B. Squire, and S.Q. Khan C-terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial infarction J Card Fail 14 2008 739 745
216. T. Keller, S. Tzikas, and T. Zeller Copeptin improves early diagnosis of acute myocardial infarction J Am Coll Cardiol 55 2010 2096 2106
217. S. Kojima, T. Funahashi, and F. Otsuka Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction Atherosclerosis 194 2007 204 213
218. R. Schnabel, C.M. Messow, and E. Lubos Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study Eur Heart J 29 2008 649 657
219. H. Teoh, M.H. Strauss, P.E. Szmitko, and S. Verma Adiponectin and myocardial infarction: a paradox or a paradigm? Eur Heart J 27 2006 2266 2268
220. R. Wolk, P. Berger, R.J. Lennon, E.S. Brilakis, D.E. Davison, and V.K. Somers Association between plasma adiponectin levels and unstable coronary syndromes Eur Heart J 28 2007 292 298
221. S. Kojima, T. Funahashi, and T. Sakamoto The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction Heart 89 2003 667
222. E. Cavusoglu, C. Ruwende, and V. Chopra Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain Eur Heart J 27 2006 2300 2309
223. J. Bartunek, L. Delrue, and F. Van Durme Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load J Am Coll Cardiol 52 2008 2166 2174
224. K.M. Eggers, P.W. Armstrong, and R.M. Califf ST2 and mortality in non-ST-segment elevation acute coronary syndrome Am Heart J 159 2010 788 794
225. R.A. Weir, A.M. Miller, and G.E. Murphy Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction J Am Coll Cardiol 55 2010 243 250
226. J. Diez Serum soluble ST2 as a biochemical marker of acute heart failure: future areas of research J Am Coll Cardiol 52 2008 1466 1467
227. S.U. Rehman, T. Mueller, and J.L. Januzzi Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure J Am Coll Cardiol 52 2008 1458 1465
228. T. Mueller, B. Dieplinger, A. Gegenhuber, W. Poelz, R. Pacher, and M. Haltmayer Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure Clin Chem 54 2008 752 756
229. M. Shimpo, D.A. Morrow, and E.O. Weinberg Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction Circulation 109 2004 2186 2190
230. S.A. Moore, and J.L. Januzzi Jr. Found in translation soluble ST2 and heart disease J Am Coll Cardiol 55 2010 251 253
231. M.S. Sabatine, D.A. Morrow, and L.J. Higgins Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation 117 2008 1936 1944
232. A.M. Brown, A.H. Wu, P. Clopton, J.L. Robey, and J.E. Hollander ST2 in emergency department chest pain patients with potential acute coronary syndromes Ann Emerg Med 50 2007 153 158 [8 e1]
233. C. Iribarren, B.H. Phelps, and J.A. Darbinian Circulating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control study BMC Cardiovasc Disord 11 2011 31
234. K.W. Lee, G.Y. Lip, A.D. Blann, K.W. Lee, G.Y.H. Lip, and A.D. Blann Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes Circulation 110 2004 2355 2360
235. R.A. Weir, K.S. Chong, and J.R. Dalzell Plasma apelin concentration is depressed following acute myocardial infarction in man Eur J Heart Fail 11 2009 551 558
236. A.M. Tycinska, B. Sobkowicz, and B. Mroczko The value of apelin-36 and brain natriuretic peptide measurements in patients with first ST-elevation myocardial infarction Clin Chim Acta 411 2010 2014 2018
237. B. Bigalke, M. Haap, and K. Stellos Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain Thromb Res 125 2010 e184 e189
238. H.E. Ataoglu, F. Yilmaz, and I. Uzunhasan Procalcitonin: a novel cardiac marker with prognostic value in acute coronary syndrome J Int Med Res 38 2010 52 61
239. D. Kelly, S.Q. Khan, and O. Dhillon Procalcitonin as a prognostic marker in patients with acute myocardial infarction Biomarkers 15 2010 325 331
240. G.K. Wang, J.Q. Zhu, and J.T. Zhang Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans Eur Heart J 31 2010 659 666
241. B. Meder, A. Keller, and B. Vogel MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction Basic Res Cardiol 106 2011 13 23
242. J. Ai, R. Zhang, and Y. Li Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction Biochem Biophys Res Commun 391 2010 73 77
243. M.Z. Gad, S.I. Hassanein, and S.M. Abdel-Maksoud Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine in coronary artery disease Biomarkers 15 2010 746 752
244. M. Zeller, C. Korandji, and J.C. Guilland Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction Arterioscler Thromb Vasc Biol 28 2008 954 960
245. L.M. Biasucci, G. Biasillo, A. Stefanelli, L.M. Biasucci, G. Biasillo, and A. Stefanelli Procalcitonin and acute coronary syndromes: a new biomarker for an old disease Intern 4 2009 363 365
246. N. Kafkas, K. Venetsanou, and S. Patsilinakos Procalcitonin in acute myocardial infarction Acute Card Care 10 2008 30 36
247. T. Adachi, M. Nakanishi, and Y. Otsuka Plasma microRNA 499 as a biomarker of acute myocardial infarction Clin Chem 56 2010 1183 1185
248. T. Yada, S. Kaji, and T. Akasaka Changes of asymmetric dimethylarginine, nitric oxide, tetrahydrobiopterin, and oxidative stress in patients with acute myocardial infarction by medical treatments Clin Hemorheol Microcirc 37 2007 269 276
249. Z. Yang, and D. Min Zhou Cardiac markers and their point-of-care testing for diagnosis of acute myocardial infarction. Clin Biochem 39 2006 771 780
250. F. Di Serio, G. Antonelli, P. Trerotoli, M. Tampoia, A. Matarrese, and N. Pansini Appropriateness of point-of-care testing (POCT) in an emergency department Clin Chim Acta 333 2003 185 189
251. H.M. Azzazy, and R.H. Christenson Cardiac markers of acute coronary syndromes: is there a case for point-of-care testing? Clin Biochem 35 2002 13 27
252. J. McCord, R.M. Nowak, and P.A. McCullough Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I Circulation 104 2001 1483 1488
253. P. Stubbs, and P.O. Collinson Point-of-care testing: a cardiologist's view Clin Chim Acta 311 2001 57 61
254. S.W. Goodacre, M. Bradburn, E. Cross, P. Collinson, A. Gray, and A.S. Hall The Randomised Assessment of Treatment using Panel Assay of Cardiac Markers (RATPAC) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department Heart 97 2011 190 196
255. J.M. Hicks, R. Haeckel, C.P. Price, K. Lewandrowski, and A.H. Wu Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium Clin Chim Acta 303 2001 1 17
256. S. Altinier, M. Zaninotto, and M. Mion Point-of-care testing of cardiac markers: results from an experience in an Emergency Department Clin Chim Acta 311 2001 67 72
257. A.B. Storrow, and W.B. Gibler The role of cardiac markers in the emergency department Clin Chim Acta 284 1999 187 196
258. F.S. Apple, B. Koplen, and M.M. Murakami Preliminary evaluation of the Vitros ECi cardiac troponin I assay Clin Chem 46 2000 572 574
259. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine J Am Coll Cardiol 50 2007 e1 e157
260. M.C. Kontos, F.P. Anderson, C.M. Hanbury, C.S. Roberts, W.G. Miller, and R.L. Jesse Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction Am J Emerg Med 15 1997 14 19
261. S.M. Ng, P. Krishnaswamy, R. Morissey, P. Clopton, R. Fitzgerald, and A.S. Maisel Ninety-minute accelerated critical pathway for chest pain evaluation Am J Cardiol 88 2001 611 617
262. G.S. Hillis, N. Zhao, P. Taggart, W.C. Dalsey, and A. Mangione Utility of cardiac troponin I, creatine kinase-MB(mass), myosin light chain 1, and myoglobin in the early in-hospital triage of «high risk» patients with chest pain Heart 82 1999 614 620
263. S.P. Macdonald, Y. Nagree, S.P.J. Macdonald, and Y. Nagree Rapid risk stratification in suspected acute coronary syndrome using serial multiple cardiac biomarkers: a pilot study Emerg Med Australas 20 2008 403 409
264. S. Rathore, P. Knowles, A.P. Mann, and P.A. Dodds Is it safe to discharge patients from accident and emergency using a rapid point of care Triple Cardiac Marker test to rule out acute coronary syndrome in low to intermediate risk patients presenting with chest pain? Eur J Intern Med 19 2008 537 540
265. L.K. Newby, A.B. Storrow, and W.B. Gibler Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study Circulation 103 2001 1832 1837
266. C.J. McCann, B.M. Glover, and I.B. Menown Investigation of a multimarker approach to the initial assessment of patients with acute chest pain Adv Ther 26 2009 531 534
267. C.J. McCann, B.M. Glover, and I.B. Menown Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T Eur Heart J 29 2008 2843 2850
268. R.M. Oemrawsingh, T. Lenderink, and K.M. Akkerhuis Multimarker risk model containing troponin-T, interleukin 10, myeloperoxidase and placental growth factor predicts long-term cardiovascular risk after non-ST-segment elevation acute coronary syndrome Heart 97 2011 1061 1066
269. J.C. Kaski, D.J. Fernandez-Berges, and L. Consuegra-Sanchez A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study Atherosclerosis 212 2010 636 643
270. C.J. McCann, B.M. Glover, and I.B. Menown Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain Am J Cardiol 103 2009 22 28
271. J.C. Kaski, D.J. Fernandez-Berges, and L. Consuegra-Sanchez A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study Atherosclerosis 212 2 2010 636 643
272. T. Brugger-Andersen, H. Aarsetoy, and H. Grundt The long-term prognostic value of multiple biomarkers following a myocardial infarction Thromb Res 123 2008 60 66
273. P. Fitzgerald, S.W. Goodacre, and E. Cross Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel assay of cardiac markers (RATPAC) trial Acad Emerg Med 18 2011 488 495